UK 100Short
Further entry for the road down.
It is almost certain that we will see some form of lockdown at this point with the devolved nations and the health secretary laying the groundstone for a circuit-breaker type lockdown.
The current pullback is making for a good entry position following the sell off in the asian market. My target is still around 7050, I don't see this breaking out of this upward trend as a result of this and any further pips would be greed at this point.
My rationale is that the infrastructure is in place for a further lockdown, businesses are already well adapted to these circumstances and I feel that there would have to be another fundamental precipitant to see price action below 7000.
My view on Omicron remains constant. High transmisibillity moderate pathogenicity. This however in a co-morbid population could be dangerous and the forthcoming hospital number spike is inevitable.
Trade Safe. See you at the bottom!
The current pullback is making for a good entry position following the sell off in the asian market. My target is still around 7050, I don't see this breaking out of this upward trend as a result of this and any further pips would be greed at this point.
My rationale is that the infrastructure is in place for a further lockdown, businesses are already well adapted to these circumstances and I feel that there would have to be another fundamental precipitant to see price action below 7000.
My view on Omicron remains constant. High transmisibillity moderate pathogenicity. This however in a co-morbid population could be dangerous and the forthcoming hospital number spike is inevitable.
Trade Safe. See you at the bottom!
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.